Importin 3D structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 38: | Line 38: | ||
**[[6bvt]] – mIPO NLS-binding domain <br /> | **[[6bvt]] – mIPO NLS-binding domain <br /> | ||
**[[4u5v]], [[4u5u]], [[4u5s]], [[4u5o]], [[4u5n]], [[4u5l]], [[4u58]], [[4u54]] – mIPO NLS-binding domain + inhibitor<br /> | **[[4u5v]], [[4u5u]], [[4u5s]], [[4u5o]], [[4u5n]], [[4u5l]], [[4u58]], [[4u54]] – mIPO NLS-binding domain + inhibitor<br /> | ||
**[[7s1e]] – IPO – guinea pig<br /> | |||
*''IPO-α 1 complex with NLS peptide'' | *''IPO-α 1 complex with NLS peptide'' | ||
Line 46: | Line 47: | ||
**[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | **[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
**[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | **[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | ||
**[[7n8j]] – hIPO NLS-binding domain + BIMAX peptide<br /> | |||
**[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | ||
**[[4mz5]], [[4mz6]] – mIPO NLS-binding domain 70-528 + dUTPase<br /> | **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain 70-528 + dUTPase<br /> | ||
Line 56: | Line 58: | ||
**[[5ekg]], [[5ekf]], [[5e6q]] – mIPO NLS-binding domain + XPG2<br /> | **[[5ekg]], [[5ekf]], [[5e6q]] – mIPO NLS-binding domain + XPG2<br /> | ||
**[[5d5k]] – mIPO NLS-binding domain + PARP 2<br /> | **[[5d5k]] – mIPO NLS-binding domain + PARP 2<br /> | ||
**[[7l04]] – mIPO NLS-binding domain + adeno-associated virus<br /> | |||
**[[5ctt]] – mIPO NLS-binding domain + SART3/TIP110<br /> | **[[5ctt]] – mIPO NLS-binding domain + SART3/TIP110<br /> | ||
**[[5b56]] – mIPO NLS-binding domain + HIV-1 VPR<br /> | **[[5b56]] – mIPO NLS-binding domain + HIV-1 VPR<br /> | ||
Line 66: | Line 69: | ||
**[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | **[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | ||
**[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | **[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | ||
**[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> | **[[5u5p]], [[5u5r]], [[6wba]], [[6wbb]], [[6wbc]], [[7m60]] – mIPO NLS-binding domain + MLH1 peptide <br /> | ||
**[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | **[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | ||
**[[6iw8]], [[6iwa]] – mIPO NLS-binding domain + GM130 peptide <br /> | **[[6iw8]], [[6iwa]] – mIPO NLS-binding domain + GM130 peptide <br /> | ||
Line 73: | Line 76: | ||
**[[6p6a]] – mIPO NLS-binding domain + NIT-2 peptide <br /> | **[[6p6a]] – mIPO NLS-binding domain + NIT-2 peptide <br /> | ||
**[[6p6e]] – mIPO NLS-binding domain + PAC3 peptide <br /> | **[[6p6e]] – mIPO NLS-binding domain + PAC3 peptide <br /> | ||
**[[7jk7]] – mIPO NLS-binding domain + LSD1 peptide <br /> | **[[7jjm]], [[7jk7]] – mIPO NLS-binding domain + LSD1 peptide <br /> | ||
**[[7jvo]] – mIPO NLS-binding domain + ACE2 peptide <br /> | |||
**[[7rg4]], [[7rg5]] – mIPO NLS-binding domain + p50 peptide <br /> | |||
**[[6wx7]] – mIPO NLS-binding domain + SOX2 peptide <br /> | |||
**[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | ||
**[[4b8p]] – rIPO NLS-binding domain + A89<br /> | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | ||
Line 120: | Line 126: | ||
**[[3fex]], [[3fey]] – mIPO NLS-binding domain + nuclear CAP-binding protein<br /> | **[[3fex]], [[3fey]] – mIPO NLS-binding domain + nuclear CAP-binding protein<br /> | ||
**[[7rfx]], [[7rfz]], [[7rg0]], [[7rg1]], [[7rg2]], [[7rg3]], [[7rg6]] – mIPO + ORF4b<br /> | |||
*IPO-α 3 | *IPO-α 3 | ||
Line 129: | Line 136: | ||
**[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | **[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | ||
**[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | **[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | ||
**[[7rfy]] – hIPO + ORF4b<br /> | |||
**[[6wx8]] – hIPO + SOX2<br /> | |||
*IPO-α 5 | |||
**[[6wx9]] – hIPO + SOX2<br /> | |||
*IPO-α 6 | *IPO-α 6 | ||
Line 151: | Line 164: | ||
**[[1qgx]], [[1qgk]] – hIPO + IPO-α 2 IBB domain<br /> | **[[1qgx]], [[1qgk]] – hIPO + IPO-α 2 IBB domain<br /> | ||
**[[1ibr]] – hIPO + GTPase Ran<br /> | **[[1ibr]] – hIPO + GTPase Ran<br /> | ||
**[[ | **[[6n88]], [[6n89]] – hIPO + H1.0 – Cryo EM<br /> | ||
**[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | **[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | ||
**[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | **[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | ||
**[[2p8q]], [[2q5d]], [[2qna]], [[3lww]] – hIPO + RNA U transporter N terminal<br /> | **[[2p8q]], [[2q5d]], [[2qna]], [[3lww]] – hIPO + RNA U transporter N terminal<br /> | ||
**[[1qgr]], [[3w5k]] – hIPO + zinc finger protein SNAI1<br /> | **[[1qgr]], [[3w5k]] – hIPO + zinc finger protein SNAI1<br /> | ||
**[[1ukl]] – mIPO + SREBP-2<br /> | |||
**[[2bku]], [[3ea5]] – yIPO + GTPase Ran<br /> | |||
**[[5owu]] – yIPO + Nup1<br /> | **[[5owu]] – yIPO + Nup1<br /> | ||
*IPO-β 2 (Transportin 1) | *IPO-β 2 (Transportin 1) |
Revision as of 10:38, 3 October 2021
3D structures of importin3D structures of importin
Updated on 03-October-2021